🎯Patients with a positive mpMRI (PI-RADS ≥3) but negative target & systematic biopsies still face risks of prostate cancer (26.8%) and clinically significant prostate cancer (19.3%). Follow-up strategies matter! 📈
🔹 Best outcomes: repeat mpMRIs + biopsy based on clinical/radiological triggers (96% csPCA-free at 2 yrs).
🔹 Predictors: age, prostate volume, PI-RADS score, ASAP, & biopsy core count
Tailored follow-up is essential for managing these high-risk cases. 👨⚕️📊 #ProstateCancer #mpMRI #Urology
https://t.co/e5T2FmWdrz @EAU_YAUProstate@EAUYAUrology
No próximo sábado 31/08, a Associação Gaúcha de Radiologia promove uma série de workshops práticos em abdômen, tórax, MSK e neuro! Evento presencial em Porto Alegre no Hotel Laghetto Moinhos! Inscrições https://t.co/Gp02pF3s2e
🌟 I am delighted to share this new article about Strategies to improve image quality in prostate MRI!
We emphasized the main checkpoints for Quality control and Quality assurance.
Check it out!
https://t.co/W1XoUf8gXA
@baroni_ronaldo@hosp_einstein@ImagingProstate
🚨 Breaking results 🚨 @PrimeMRI study presented at #EAU24@Uroweb. This 🌍 multicentre trial (n=555, 22 sites) showed that biparametric MRI without contrast is non-inferior 2 multiparametric MRI & should be the new standard for prostate cancer diagnosis if image quality is good
👏 Happy to see this Review just published in @AJR_Radiology!
👉 Check it out for a critical appraisal of the New Prostate MRI Scoring Systems:
🔘 PI-QUAL
🔘 PRECISE
🔘 PI-RR
🔘 PI-FAB
https://t.co/dcqT5b0oru
@danatsouza diffuse pancreatic lipomatosis, cholelithiasis and left seminal vesicle agenesis, probable cystic fibrosis. And also mild right colon diverticulitis. Beautiful case.